Astellas Looks To India As Part Of Japanese Drug Maker Trend
This article was originally published in PharmAsia News
Executive Summary
Astellas Pharma of Japan is considering becoming active in India as Japanese drug makers look to that country to expand sales and manufacture their products. A consultant said Japanese companies increasingly are looking to expand in India because the country is particularly suitable for pharmaceutical and chemical companies. Daiichi Sankyo is buying Ranbaxy Laboratories, Eisai already is expanding manufacturing and sales operations into India, both an indication the trend is likely to accelerate. (Click here for more - a subscription may be required
You may also be interested in...
Cosmetic And Personal Care Trademark Review: 16 April
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.
Health And Wellness Weekly Trademarks Review: 16 April
Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.
Beauty Packaging Producers: July Marks Registration Deadline With PRO In Three States
Companies considered producers of single-use packaging in Oregon, Colorado and California must register with Circular Action Alliance, the leading (and currently only) producer responsibility organization, by 1 July 2024 under new state recycling laws.